Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Document › Details

PerkinElmer, Inc.. (10/30/17). "Press Release: PerkinElmer Elects Pascale Witz to Its Board of Directors". Waltham, MA.

Organisation Organisation PerkinElmer Inc. (NYSE: PKI)
  Group PerkinElmer (Group)
Products Product laboratory equipment and instruments
  Product 2 diagnostics (medical/biological)
Persons Person Witz, Pascale (Sanofi 201307–201605 EVP before GE Healthcare + Becton Dickinson LEFT 6/16)
  Person 2 Friel, Robert F. (PerkinElmer 200802– CEO before COO before President Life+Analytical joined 1999 as CFO)

PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world , today announced that Pascale Witz, MBA, MSc, has been elected to its Board of Directors, effective immediately.

"We would like to extend a warm welcome to Pascale as the newest member of our Board," said Robert Friel, chairman and chief executive of PerkinElmer. "She brings a wide range of commercial healthcare and strategic management experience across the pharmaceutical, medical device, and diagnostics industries, and I am confident that her leadership will be invaluable in helping drive the future direction of the Company."

Witz has more than 30 years of global experience, most recently serving as executive vice president, Global Diabetes and Cardiovascular for Sanofi, S.A. Prior to Sanofi, she held several leadership positions during her 17 years with GE Healthcare, including the role of president and CEO of its medical diagnostics division. She began her career in research before moving to a marketing role at Becton Dickinson France in 1991 and to GE Healthcare in 1996.

Witz currently serves on the Board of Directors of Horizon Pharma Plc, Regulus Therapeutics, Inc., Fresenius Medical Care AG & Co. KGaA, Savencia SA, and French-American Foundation-France. Witz received her MSc in biochemistry from the Institut National des Sciences Appliquées de Lyon, France and an MBA in economics and marketing from INSEAD, Fontainebleau, France.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of 9,000 employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets. Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us. The Company reported revenue of approximately $2.1 billion in 2016, serves customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at

PerkinElmer, Inc.

Brian Willinsky, +1- 781-663-5728

Record changed: 2023-06-05


Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for PerkinElmer (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px

» top